BioSpace News Archive

BioMidwest

Exicure to Participate in Upcoming Scientific Conferences

Exicure , Inc. today announced participation in the following scientific conferences during the month of September: TIDES USA 2021 Poster presentation: “Biodistribution of Spherical Nucleic Acids in the Rat CNS Following ICM and IT Delivery” September 20 – 30, 2021

September 15, 2021
·
1 min read
Genetown

Vigil Neuroscience Announces First Subject Enrolled in a Natural History Study of Patients with Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia (ALSP)

Vigil Neuroscience announced today the enrollment of the first subject in a natural history study dedicated to patients with adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP).

September 15, 2021
·
3 min read
Drug Development

Actinium Completes Enrollment in the Pivotal Phase 3 SIERRA Trial of Iomab-B

Actinium Pharmaceuticals, Inc. today announced that it has completed enrollment of the pivotal Phase 3 SIERRA trial for Iomab-B.

September 15, 2021
·
13 min read
Biotech Bay

Allay Therapeutics Completes Oversubscribed $60M Financing to Advance Ultra-Sustained Pain Platform

Allay Therapeutics today announced the completion of its oversubscribed $60M Series C financing, led by Arboretum Ventures.

September 15, 2021
·
3 min read
Deals

Flywheel and Radiologics Join Forces to Create a Truly Unique Global Network for Biomedical Research and Collaboration

Flywheel, the leading biomedical research data management platform, today announces the acquisition of St. Louis-based Radiologics.

September 15, 2021
·
4 min read
Drug Development

SAB Biotherapeutics Announces Completion of Enrollment in Phase 2a Challenge Trial of SAB-176 for the Treatment of Seasonal Influenza

SAB Biotherapeutics today announced the completion of enrollment in its Phase 2a clinical trial evaluating the safety and efficacy of SAB-176 in a challenge study.

September 15, 2021
·
8 min read
Pharmacogenomics Market is Projected to Witness Vigorous Expansion by 2025

Pharmacogenomics is the study of inherited variations in human genes that affect an individual’s reaction to a particular drug.

September 15, 2021
·
5 min read
Home Diagnostics Market | How has COVID-19 affected the market?

The global home diagnostics market is witnessing a growth and shall continue to expand at a high pace on account of the rising disposable income of people across nations, which enable them to afford products that enable self care.

September 15, 2021
·
7 min read
Drug Development

GenSight Biologics Announces Positive Data Safety Monitoring Board Review of PIONEER Phase I/II Clinical Trial of GS030 as Optogenetic Treatment for Retinitis Pigmentosa

GenSight Biologics announced that the independent Data Safety Monitoring Board completed its third safety review of the ongoing PIONEER Phase I/II clinical trial of GS030 combining AAV2-based gene therapy with optogenetics for the treatment of Retinitis Pigmentosa.

September 15, 2021
·
7 min read
Business

Dr. David Berglund and Dr. Stephen Wooding nominated as new board members at XNK Therapeutics

XNK Therapeutics AB announced that Dr. David Berglund and Dr. Stephen Wooding are proposed to be appointed members of the Board of Directors.

September 15, 2021
·
3 min read